Iridina Due 0.5mg/ml eye drops solution 10ml

Iridina Due 0.5mg/ml eye drops solution 10ml is an ophthalmic treatment formulated to relieve irritation , burning and redness of the eyes, often accompanied by excessive tearing and sensitivity to light . This eye drop contains naphazoline hydrochloride , an active ingredient known for its decongestant properties, which helps reduce swelling and redness of the eyes. The solution is enriched with excipients such as Benzalkonium chloride , Sodium hyaluronate and distilled Chamomile water , which help improve ocular comfort. Ideal for those looking for quick and effective relief from the symptoms of eye strain, Iridina Due is a targeted choice for eye well-being.

ACTIVE INGREDIENTS

Active ingredients contained in Iridina Due 0.5mg/ml eye drops solution 10ml - What is the active ingredient in Iridina Due 0.5mg/ml eye drops solution 10ml?

10 ml of eye drops contain naphazoline hydrochloride 5 mg Excipients with known effect: Benzalkonium chloride For the full list of excipients, see section 6.1

EXCIPIENTS

Composition of Iridina Due 0.5mg/ml eye drops solution 10ml - What does Iridina Due 0.5mg/ml eye drops solution 10ml contain?

Sodium chloride, Sodium dihydrogen phosphate dihydrate, Sodium hydroxide, Sodium hyaluronate, Benzalkonium chloride, Hamamelis distilled water, Chamomile distilled water, Purified water

DIRECTIONS

Therapeutic indications Iridina Due 0.5mg/ml eye drops solution 10ml - Why is Iridina Due 0.5mg/ml eye drops solution 10ml used? What is it used for?

Irritation, burning, redness of the eye, with excessive tearing, and sensitivity to light.

CONTRAINDICATIONS SIDE EFFECTS

Contraindications Iridina Due 0.5mg/ml eye drops solution 10ml - When should Iridina Due 0.5mg/ml eye drops solution 10ml not be used?

Hypersensitivity to the active substance or other closely related substances from a chemical point of view (in particular xylometazoline, oxymetazoline, tetryzoline) or to any of the excipients listed in paragraph 6.1. The product must not be used in patients suffering from glaucoma or other eye diseases. Contraindicated in children under twelve years of age. Contraindicated in case of treatment with MAO inhibitors (see paragraph 4.5).

DOSAGE

Quantity and method of taking Iridina Due 0.5mg/ml eye drops solution 10ml - How do you take Iridina Due 0.5mg/ml eye drops solution 10ml?

When you feel a burning sensation, squeeze one or two drops of eye drops into the inner corner of each eye, tilting your head back. The product should not be used after 28 days from first opening. The medicine should not be used for more than 4 consecutive days, unless otherwise indicated by your doctor. Strictly follow the recommended doses. A higher dosage of the product, even if taken topically and for a short period of time, can give rise to serious systemic effects.

CONSERVATION

Storage Iridina Due 0.5mg/ml eye drops solution 10ml - How is Iridina Due 0.5mg/ml eye drops solution 10ml stored?

This medicinal product does not require any special storage conditions. The shelf life after first opening the bottle is 28 days.

WARNINGS

Warnings Iridina Due 0.5mg/ml eye drops solution 10ml - About Iridina Due 0.5mg/ml eye drops solution 10ml it is important to know that:

In case of persistence or worsening of symptoms after a short period of treatment, consult your doctor. In any case, the product should not be used for more than 4 consecutive days. (see section 4.2) If you experience side effects (eye pain, changes in vision or persistent redness) in a period of less than 4 days, stop treatment and consult your doctor. The product is not suitable for the treatment of infections, pus, foreign bodies in the eye, mechanical, chemical and heat damage. These conditions require medical attention. Although the product has poor serum absorption, it should be used with caution in patients with hypertension, hyperthyroidism, heart disease, hyperglycemia (diabetes) and bronchial asthma. Since the product contains Benzalkonium Chloride, soft contact lenses should not be worn during treatment. If contact lenses are used, they should be removed before instilling the eye drops and can be reinserted after 15 minutes. Keep out of reach of children as accidental ingestion may cause CNS depression (marked sedation, hypotonia, coma). In such cases, immediate medical assistance is always necessary.

INTERACTIONS

Interactions Iridina Due 0.5mg/ml eye drops solution 10ml - Which medicines or foods can modify the effect of Iridina Due 0.5mg/ml eye drops solution 10ml?

MAO inhibitors enhance the pharmacological effects of naphazoline. Concomitant use is not recommended. Allow at least two weeks to elapse between the start of naphazoline therapy and the end of MAO inhibitor therapy.

SIDE EFFECTS

Like all medicines, Iridina Due 0.5mg/ml eye drops solution 10ml can cause side effects - What are the side effects of Iridina Due 0.5mg/ml eye drops solution 10ml?

The use of the product may sometimes cause pupil dilation, systemic absorption effects (hypertension, cardiac disorders, hyperglycemia), increased intraocular pressure, nausea, headache. Hypersensitivity phenomena may rarely occur. In this case, treatment should be stopped and the doctor should be consulted so that, if necessary, appropriate therapy can be instituted. Cases of corneal calcification associated with the use of eye drops containing phosphates in patients with significantly damaged corneas have been reported very rarely. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorisation of the medicinal product is important, as it allows continuous monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse

OVERDOSE

Overdose Iridina Due 0.5mg/ml eye drops solution 10ml - What are the risks of Iridina Due 0.5mg/ml eye drops solution 10ml in case of overdose?

In case of overdose by accidental oral administration, especially in children, there may be manifestations of depression at the level of the central nervous system with phenomena of bradypnea, sensation of cold skin, drowsiness, tachycardia, sweating, mental confusion and coma. If this occurs: gastric lavage, sedation with diazepam and general support measures.

PREGNANCY AND BREASTFEEDING

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking Iridina Due 0.5mg/ml eye drops, solution 10ml.

Pregnancy There are no data on the use of naphazoline in pregnant women. IRIDINA DUE eye drops should be administered only if the potential benefit justifies the potential risk to the fetus. Breastfeeding There are no data on the possible excretion of the active substance through breast milk. A risk to newborns/children cannot be excluded.

DRIVING AND USE OF MACHINERY

Taking Iridina Due 0.5mg/ml eye drops solution 10ml before driving or using machines - Does Iridina Due 0.5mg/ml eye drops solution 10ml affect driving or using machines?

Iridina Due may cause transient visual difficulty following instillation. Patients should not drive or operate machinery until visual function is restored.